Clinical Trials Browser

Phase EARLY_PHASE1 × OTHER × Solid Tumor × Clear all

NCT05645523 2026-02-25

Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06515626 2024-09-25

Genetically Modified T Cells Treating Malignant Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05831033 2024-09-19

Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients with Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT04552418 2024-02-28

Intestinal Microbiome Modification With Resistant Starch in Patients Treated With Dual Immune Checkpoint Inhibitors

Phase EARLY_PHASE1 Completed

Other solid neoplasm

Solid Tumor

NCT05724732 2023-02-13

Exploratory Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Gynecologic Tumors

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

NCT05638828 2022-12-06

A Study of RD14-01 in Patients With Advanced Solid Tumors

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

NCT05373147 2022-10-26

αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

NCT05284968 2022-03-17

RD07 Cell Injection in the Treatment of Patients With Advanced Claudin18.2 Positive Solid Tumors

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

NCT05166070 2021-12-21

An Exploratory Clinical Study of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT04046016 2019-08-06

A Study Using Whole-body PET After Oral Microdose of 18F-labeled Liporaxel in Patients With Solid Tumor

Phase EARLY_PHASE1 Completed

Other solid neoplasm

Solid Tumor

NCT02446431 2015-05-18

Metronomic

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor